Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Idera Pharmaceuticals Inc. (IDRA)

2.68   0.07 (2.68%) 09-20 21:03
Open: 2.6 Pre. Close: 2.61
High: 2.75 Low: 2.47
Volume: 388,095 Market Cap: 94M
Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company is headquartered in Exton, Pennsylvania and currently employs 36 full-time employees. The firm utilizes two drug discovery technology platforms to design and develop drug candidates, which include Toll-like receptor (TLR) targeting technology and third-generation antisense (3GA) technology. Using TLR technology, the Company designs synthetic oligonucleotide-based drug candidates to act by modulating the activity of specific TLRs. Using its 3GA technology, the Company is developing drug candidates to turn off the messenger ribo nucleic acid (mRNA) associated with disease causing genes. The firm's drug candidates include IMO-8400, IMO-2125 and IMO-9200. The firm has designed TLR antagonists and agonists to act by modulating the activity of targeted TLRs. The company is developing its 3GA technology to turn off the mRNA associated with disease causing genes.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.752 - 2.76 2.76 - 2.769
Low: 2.447 - 2.456 2.456 - 2.467
Close: 2.663 - 2.678 2.678 - 2.694

Technical analysis

as of: 2020-09-18 4:32:07 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 3.21     One year: 3.75
Support: Support1: 2.16    Support2: 1.80
Resistance: Resistance1: 2.75    Resistance2: 3.21
Pivot: 2.15
Moving Average: MA(5): 2.42     MA(20): 2.13
MA(100): 1.98     MA(250): 1.93
MACD: MACD(12,26): 0.11     Signal(9): 0.04
Stochastic oscillator: %K(14,3): 91.84     %D(3): 79.18
RSI: RSI(14): 70.65
52-week: High: 3.10  Low: 0.81  Change(%): -8.5
Average Vol(K): 3-Month: 34758  10-Days: 32095

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
IDRA has closed above the upper band by 4.9%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 92.8% wider than normal. The large width of the bands suggest high volatility as compared to IDRA's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue.

Headline News

Thu, 17 Sep 2020
Idera Pharmaceuticals Inc. (IDRA) Soars 5.67% on September 17 - Equities.com

Wed, 16 Sep 2020
What is the Market's View on Idera Pharmaceuticals Inc (IDRA) Stock's Price and Volume Trends - InvestorsObserver

Tue, 15 Sep 2020
Barclays slashes price target on Idera Pharmaceuticals Inc. [IDRA] – find out why. - The DBT News

Tue, 15 Sep 2020
Where Does Wall Street Think Idera Pharmaceuticals Inc (IDRA) Stock Will Go? - InvestorsObserver

Tue, 15 Sep 2020
No matter how cynical the overall market is Idera Pharmaceuticals Inc. (IDRA) performance over the last week is recorded 2.55% - News Daemon

Thu, 10 Sep 2020
Why Idera Pharmaceuticals' (NASDAQ:IDRA) CEO Pay Matters - Yahoo Finance

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Underperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Outperform Debt to Equity: Underperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 35
Shares Float (M) 26
% Held by Insiders 18.24
% Held by Institutions 27.53
Shares Short (K) 768
Shares Short P. Month (K) 415

Stock Financials

EPS -2.627
EPS Est This Year -0.480
EPS Est Next Year -0.500
Book Value (p.s.) -0.520
Profit Margin
Operating Margin
Return on Assets (ttm) -62.2
Return on Equity (ttm) -331.3
Qtrly Rev. Growth
Gross Profit (p.s.) -0.684
Sales Per Share
EBITDA (p.s.) -1.257
Qtrly Earnings Growth
Operating Cash Flow (M) -40
Levered Free Cash Flow (M) -24

Stock Valuations

PE Ratio -1.02
PEG Ratio
Price to Book value -5.15
Price to Sales
Price to Cash Flow -2.34

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.